Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LATUDA vs LEMBOREXANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LATUDA vs LEMBOREXANT: Safety Overview

Metric LATUDA LEMBOREXANT
Total FAERS Reports 130 989
Deaths Reported 10 44
Death Rate 7.7% 4.4%
Hospitalizations 42 278
Average Patient Age 42.5 yrs 58.9 yrs
% Female Patients N/A 63.4%
FDA Approval Date N/A Apr 7, 2020
Manufacturer N/A Eisai Inc.
Route N/A ORAL
Marketing Status N/A Prescription